Reference no: EM133559094

Question 1-T1: TR is a 17 yo that takes several medications. What is the difference between a pharmacokinetic interaction and a pharmacodynamic drug interaction? Please give an example of each. Please be as detailed as possible.

Question 1-T2: What is the bioavailability of this product?

Assuming MR. Jones is in the hospital for XYZ infection but is taking all taking food and other meds by mouth is there an advantage of giving him this med IV vs PO?

Question 1-T3: Some adverse effects are an extension of the medication's pharmacology and some are idiosyncratic (not always predictable). Explain which of the following are an extension of the medication's pharmacologic effect, which may be dose-related and which are idiosyncratic and not dose related.

Question 1-T4: SA is a 12 yo to be started on a new medication for asthma. Why may a medication be on the market for several years prior to us learning about all if its side effects and drug interactions?

Question2 - T1: LP is a 72 yo with atrial fibrillation and HTN. What would be a good agent to consider starting for the HTN and why? What are the monitoring parameters of efficacy and side effects of the agent you picked? What is the mechanism of the agent you decided to start? Please be as detailed as possible.

Question 2 - T2: JK is a 27 yo with borderline HTN normally controlled with diet and exercise. What medications may lead to an increase in BP and by what mechanism?

Question 2-T3: You have been asked to see a patient with angina and asthma. What is a good antianginal to try and why? What are the monitoring parameters for efficacy and toxicity of the agent you choose?

Question 2 -T4: PO is a 72 yo female with angina and HTN, what would your therapeutic plan look like if you were starting her on all new meds from scratch? Why did you choose each med? What are the monitoring parameters of efficacy and side effects of each medication you picked?